Evogene (EVGN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.39, -3.45% vs the prior close of $0.40.
- Volume 37.67K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EVGN slides 3.4% to $0.39. Closed at $0.39, -3.45% vs the prior close of $0.40. Day range $0.38–$0.41, opened at $0.41.
EVGN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — EVGN slides 3.4% to $0.39
- Closed at $0.39, -3.45% vs the prior close of $0.40. Day range $0.38–$0.41, opened at $0.41.
- Volume was 37.67K shares, 0.0x its 50-day average of 1.79M — lighter than usual.
- Price is -22.2% vs its 50-day average ($0.50) and -44.9% vs its 200-day average ($0.70).
- 52-week range $0.35–$1.35; today's close sits at 4% of that range, 71.4% below the 52-week high.
Oct 15, 2026 — EVGN jumps 5.3% to $0.40
- Closed at $0.40, +5.26% vs the prior close of $0.38. Day range $0.38–$0.40, opened at $0.38.
- Volume was 27.10K shares, 0.0x its 50-day average of 1.79M — lighter than usual.
- Price is -20.4% vs its 50-day average ($0.50) and -43.1% vs its 200-day average ($0.70).
- 52-week range $0.35–$1.49; today's close sits at 4% of that range, 73.2% below the 52-week high.
Oct 14, 2026 — EVGN dips 2.6% to $0.38
- Closed at $0.38, -2.56% vs the prior close of $0.39. Day range $0.37–$0.39, opened at $0.38.
- Volume was 52.60K shares, 0.0x its 50-day average of 1.80M — lighter than usual.
- Price is -25.1% vs its 50-day average ($0.51) and -46.2% vs its 200-day average ($0.71).
- 52-week range $0.35–$1.49; today's close sits at 3% of that range, 74.5% below the 52-week high.
Oct 13, 2026 — EVGN ends flat (+0.0%) to $0.39
- Closed at $0.39, +0.00% vs the prior close of $0.39. Day range $0.37–$0.40, opened at $0.39.
- Volume was 87.60K shares, 0.0x its 50-day average of 1.81M — lighter than usual.
- Price is -23.9% vs its 50-day average ($0.51) and -45.0% vs its 200-day average ($0.71).
- 52-week range $0.35–$1.49; today's close sits at 4% of that range, 73.8% below the 52-week high.
Oct 12, 2026 — EVGN rises 2.6% to $0.39
- Closed at $0.39, +2.63% vs the prior close of $0.38. Day range $0.38–$0.40, opened at $0.39.
- Volume was 106.20K shares, 0.1x its 50-day average of 1.80M — lighter than usual.
- Price is -24.4% vs its 50-day average ($0.52) and -45.3% vs its 200-day average ($0.71).
- 52-week range $0.35–$1.49; today's close sits at 4% of that range, 73.8% below the 52-week high.
Oct 9, 2026 — EVGN slides 5.0% to $0.38, 3 down days in a row
- Closed at $0.38, -5.00% vs the prior close of $0.40. Day range $0.37–$0.39, opened at $0.39.
- Volume was 105.90K shares, 0.1x its 50-day average of 1.80M — lighter than usual.
- Price is -26.5% vs its 50-day average ($0.52) and -46.9% vs its 200-day average ($0.72).
- 52-week range $0.35–$1.49; today's close sits at 3% of that range, 74.5% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — EVGN dips 2.4% to $0.40
- Closed at $0.40, -2.44% vs the prior close of $0.41. Day range $0.38–$0.41, opened at $0.39.
- Volume was 88.30K shares, 0.0x its 50-day average of 1.80M — lighter than usual.
- Price is -23.0% vs its 50-day average ($0.52) and -44.4% vs its 200-day average ($0.72).
- 52-week range $0.35–$1.50; today's close sits at 4% of that range, 73.3% below the 52-week high.
Oct 7, 2026 — EVGN dips 2.4% to $0.41
- Closed at $0.41, -2.38% vs the prior close of $0.42. Day range $0.39–$0.43, opened at $0.43.
- Volume was 82.30K shares, 0.0x its 50-day average of 1.80M — lighter than usual.
- Price is -21.3% vs its 50-day average ($0.52) and -43.2% vs its 200-day average ($0.72).
- 52-week range $0.35–$1.50; today's close sits at 5% of that range, 72.7% below the 52-week high.
Oct 6, 2026 — EVGN jumps 5.0% to $0.42
- Closed at $0.42, +5.00% vs the prior close of $0.40. Day range $0.39–$0.44, opened at $0.39.
- Volume was 625.20K shares, 0.3x its 50-day average of 1.79M — lighter than usual.
- Price is -19.6% vs its 50-day average ($0.52) and -42.1% vs its 200-day average ($0.73).
- 52-week range $0.35–$1.50; today's close sits at 6% of that range, 72.0% below the 52-week high.
- SEC filings that day: 6-K.
Oct 5, 2026 — EVGN slides 7.0% to $0.40
- Closed at $0.40, -6.98% vs the prior close of $0.43. Day range $0.37–$0.41, opened at $0.41.
- Volume was 592.90K shares, 0.3x its 50-day average of 1.78M — lighter than usual.
- Price is -23.8% vs its 50-day average ($0.52) and -45.1% vs its 200-day average ($0.73).
- 52-week range $0.35–$1.50; today's close sits at 4% of that range, 73.3% below the 52-week high.
Oct 2, 2026 — EVGN dips 2.3% to $0.43
- Closed at $0.43, -2.27% vs the prior close of $0.44. Day range $0.41–$0.45, opened at $0.41.
- Volume was 142.50K shares, 0.1x its 50-day average of 1.78M — lighter than usual.
- Price is -18.5% vs its 50-day average ($0.53) and -41.2% vs its 200-day average ($0.73).
- 52-week range $0.35–$1.50; today's close sits at 7% of that range, 71.3% below the 52-week high.
EVGN latest news & SEC filings
Every SEC filing by or about EVGN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 28, 2026 · Form POS AM — POS AM filing
POS AM filing
Sep 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 11, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 11, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 4, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 28, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade EVGN
- How much it moves: over the last 20 sessions the average daily move was 4.86% (largest 10.0%). That is a volatile stock.
- Liquidity: about 3.69M shares (≈$1.43M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.39 vs a range of $0.35–$1.35 (4% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 0 sales; latest: Leon Recanati bought 460,000 shares on Aug 11, 2026.
- Latest filings: 6-K Oct 6, 2026; 6-K Sep 30, 2026; 6-K Sep 28, 2026.
- Listing: Nasdaq · industry: Agricultural Chemicals.
EVGN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.41 | 0.41 | 0.38 | 0.39 | 37.67K |
| Oct 15, 2026 | 0.38 | 0.40 | 0.38 | 0.40 | 27.10K |
| Oct 14, 2026 | 0.38 | 0.39 | 0.37 | 0.38 | 52.60K |
| Oct 13, 2026 | 0.39 | 0.40 | 0.37 | 0.39 | 87.60K |
| Oct 12, 2026 | 0.39 | 0.40 | 0.38 | 0.39 | 106.20K |
| Oct 9, 2026 | 0.39 | 0.39 | 0.37 | 0.38 | 105.90K |
| Oct 8, 2026 | 0.39 | 0.41 | 0.38 | 0.40 | 88.30K |
| Oct 7, 2026 | 0.43 | 0.43 | 0.39 | 0.41 | 82.30K |
| Oct 6, 2026 | 0.39 | 0.44 | 0.39 | 0.42 | 625.20K |
| Oct 5, 2026 | 0.41 | 0.41 | 0.37 | 0.40 | 592.90K |
| Oct 2, 2026 | 0.41 | 0.45 | 0.41 | 0.43 | 142.50K |
| Oct 1, 2026 | 0.38 | 0.47 | 0.38 | 0.44 | 821.60K |
| Sep 30, 2026 | 0.39 | 0.42 | 0.35 | 0.40 | 9.99M |
| Sep 29, 2026 | 0.37 | 0.47 | 0.36 | 0.41 | 60.32M |
| Sep 28, 2026 | 0.41 | 0.45 | 0.35 | 0.38 | 170.80K |
| Sep 25, 2026 | 0.42 | 0.48 | 0.42 | 0.42 | 76.50K |
| Sep 24, 2026 | 0.45 | 0.49 | 0.42 | 0.42 | 284.00K |
| Sep 23, 2026 | 0.49 | 0.49 | 0.44 | 0.45 | 114.90K |
| Sep 22, 2026 | 0.48 | 0.50 | 0.46 | 0.49 | 30.20K |
| Sep 21, 2026 | 0.52 | 0.52 | 0.46 | 0.46 | 131.00K |
About Evogene
Evogene (EVGN) is listed on the Nasdaq and classified by the SEC under “Agricultural Chemicals”. Its business address is in REHOVOT, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1574565.
EVGN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Dan Michael Falk | Director | Sep 30, 2026 |
| Sarit Firon | Director | Mar 18, 2026 |
| Ofer Haviv | President and CEO | Mar 18, 2026 |
| Nir Nimrodi | Director | Sep 30, 2026 |
| Adrian John Percy | Director | Sep 30, 2026 |
| Leon Recanati | Director | Sep 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yaron Eldad | Chief Financial Officer | Mar 18, 2026 |
| Ofer Haviv | President and CEO | Mar 18, 2026 |
| Polina Ravzin | VP Finance | Apr 9, 2026 |
| Gabi Tarcic | Chief Development Officer | Aug 26, 2026 |
| Ilia Zhidkov | Chief Technology Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 11, 2026 | Leon Recanati | Buy | 460,000 | $0.64 |
| Aug 11, 2026 | Leon Recanati | Buy | 460,000 | $0.64 |
| Aug 11, 2026 | Leon Recanati | Buy | 460,000 | $0.64 |
| Aug 11, 2026 | Leon Recanati | Buy | 460,000 | $0.64 |
| Aug 4, 2026 | Leon Recanati | Buy | 800,000 | $0.50 |
| Aug 4, 2026 | Leon Recanati | Buy | 800,000 | $0.50 |
| Aug 4, 2026 | Leon Recanati | Buy | 800,000 | $0.50 |
| Aug 4, 2026 | Leon Recanati | Buy | 800,000 | $0.50 |
| Jun 4, 2026 | Gabi Tarcic | Buy | 1,129 | $0.60 |
| Jun 4, 2026 | Gabi Tarcic | Buy | 1,129 | $0.60 |
| Jun 4, 2026 | Gabi Tarcic | Buy | 1,129 | $0.60 |
| Jun 4, 2026 | Gabi Tarcic | Buy | 1,129 | $0.60 |
EVGN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
EVGN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Agricultural Chemicals
CF Industries (CF)Mosaic (MOS)Nutrien (NTR)Scotts Miracle-Gro (SMG)Icl (ICL)Cvr Partners (UAN)SenesTech (SNES)American Vanguard (AVD)Cibus (CBUS)Bioceres Crop Solutions (BIOX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EVGN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.